Research

For more information, visit us online at DawesFretzinResearch.com

Dawes Fretzin Clinical Research Group (DFCRG) is an expanding clinical research center in conjunction with a successful and reputable dermatology clinic. Through our research group we plan to offer increased treatment options to those patients with complex and resistant medical conditions.

We pride ourselves in conducting clinical trials following Good Clinical Practice (GCP) guidelines. Our staff is dedicated to both our patients' safety and to the sponsor to ensure a successful trial. Our recently expanded space and services are designed to broaden our trials beyond dermatology services. Our staff consists of physicians who specialize in dermatology, internal medicine, pulmonology and critical care.

CLINICAL RESEARCH EXPERIENCE

The DFCRG physicians and research staff have conducted Phase I, II, III and IV trials. Trials have included study medications that are administered topically, orally, subcutaneously and intravenously. Our caring staff always keeps our patient's best interest in mind. The site and its staff have worked extensively with many renowned pharmaceutical companies and Contract Research Organizations including:

  • 3M
  • Abbott Laboratories
  • Amgen
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Centocor, Inc.
  • Co Pharma
  • Covance
  • Fujisawa
  • Genentech, Inc
  • Sanofi-Synthalabo
  • Merck & Co., Inc.
  • Novartis
  • Omnicare
  • Parexel
  • Park-Davis
  • Quintiles
  • Searle
  • Takeda
  • Wyeth
  • Xoma

CONTACT INFORMATION

Kathy Byrd, RN
Clinical Coordinator
Dawes Fretzin Clinical Research Group, LLC
8103 Clearvista Parkway, Suite 260
Indianapolis, Indiana 46256
Phone: 317-621-7790, ext. 23
Fax: 317-621-7784
E-mail: Kbyrd@ecommunity.com